NasdaqGS:CGONBiotechs
Is CG Oncology (CGON) Centralizing Power To Sharpen Commercial Focus Or Stretch Leadership Too Thin?
CG Oncology recently announced the upcoming separation of President & COO Ambaw Bellete effective June 30, 2026, alongside CEO Arthur Kuan’s appointment as President and an ongoing search for a Chief Commercial Officer.
This consolidation of leadership under Kuan, combined with plans to present at the Jefferies Global Healthcare Conference 2026, highlights a pivotal moment for the company’s commercial and governance direction.
With these leadership changes at the president and COO level,...